The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreOct 2017
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Over the review period smokers in Croatia faced rising tobacco prices and bans on smoking in public places, thus making the habit both difficult and costly to maintain. Thanks also to public health campaigns discouraging smoking, this led to an increase in the number of smokers looking to kick the habit.
Croatia had long postponed the ratification of EU directive 2014/40 on tobacco use, with this risking punishment from the European Commission. However, in mid-2017, the new law was passed, introducing graphic health warnings to cover two thirds of cigarette packs, along with a written warning.
Unlike some other OTC categories, NRT smoking cessation aids face no competition from prescription medicines. Although Champix from Pfizer has been licensed in Croatia via the centralised procedure of the EMA (European Medicines Agency), it is not available, thus leaving space for the Nicorette and Niquitin brands.
The competitive landscape in NRT smoking cessation aids remained stable in 2017, with very little change having been witnessed for many years. There are only two companies present, Pfizer Croatia, which sells Johnson & Johnson’s Nicorette brand, and GlaxoSmithKline, which sells Niquitin CQ, owned by Perrigo.
Thanks to the first mover advantage, Nicorette enjoys a comfortable lead, commanding nearly two thirds of value sales, with Niquitin accounting for the remainder. Nicorette’s share has been slowly falling, mostly due to Niquitin being focused on NRT gum, which is growing in popularity.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Croatia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the NRT Smoking Cessation Aids industry in Croatia, our research will save you time and money while empowering you to make informed, profitable decisions.
The NRT Smoking Cessation Aids in Croatia market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.